60946 Federal Register / Vol. 88, No. 171 / Wednesday, September 6, 2023 / Notices 

Clifton Road NE, Mailstop H24–8, 

Atlanta, Georgia 30329–4027. 

Telephone: (404) 639–8836; Email: 

ACIP@cdc.gov. 

SUPPLEMENTARY INFORMATION: Purpose: 

The Advisory Committee on 

Immunization Practices (ACIP) is 

charged with advising the Director, 

Centers for Disease Control and 

Prevention (CDC), on the use of 

immunizing agents. In addition, under 

42 U.S.C. 1396s, the Committee is 

mandated to establish and periodically 

review and, as appropriate, revise the 

list of vaccines for administration to 

vaccine-eligible children through the 

Vaccines for Children program, along 

with schedules regarding dosing 

interval, dosage, and contraindications 

to administration of vaccines. Further, 

under applicable provisions of the 

Affordable Care Act and Section 2713 of 

the Public Health Service Act, 

immunization recommendations of 

ACIP that have been approved by the 

Director, CDC, and appear on CDC 

immunization schedules generally must 

be covered by applicable health plans. 

Matters to be Considered: The agenda 

will include discussions of maternal 

respiratory syncytial virus (RSV) 

vaccine. A recommendation vote for 

maternal RSV vaccine is scheduled. A 

Vaccines for Children vote is scheduled 

for maternal RSV vaccine. Agenda items 

are subject to change as priorities 

dictate. For more information on the 

meeting agenda, visit https://

www.cdc.gov/vaccines/acip/meetings/ 

index.html. 

Meeting Information: The meeting 

will be webcast live via the World Wide 

Web. For more information on ACIP, 

please visit the ACIP website: https://

www.cdc.gov/vaccines/acip/index.html. 

Public Participation 

Interested persons or organizations 

are invited to participate by submitting 

written views, recommendations, and 

data. Please note that comments 

received, including attachments and 

other supporting materials, are part of 

the public record and are subject to 

public disclosure. Comments will be 

posted on https://www.regulations.gov. 

Therefore, do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near-duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

Written Public Comment: The docket 

will be opened to receive written 

comments on September 7, 2023. 

Written comments must be received by 

September 21, 2023. 

Oral Public Comment: This meeting 

will include time for members of the 

public to make an oral comment. 

Priority will be given to individuals 

who submit a request to make an oral 

public comment before the meeting 

according to the procedures below. 

Procedure for Oral Public Comment: 

All persons interested in making an oral 

public comment at the September 22, 

2023, ACIP meeting must submit a 

request between September 7, 2023, and 

September 20, 2023, at https://

www.cdc.gov/vaccines/acip/meetings/ 

index.html no later than 11:59 p.m., 

EDT, September 20, 2023, according to 

the instructions provided. 

If the number of persons requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

time, CDC will conduct a lottery to 

determine the speakers for the 

scheduled public comment session. 

CDC staff will notify individuals 

regarding their request to speak by email 

on September 21, 2023. To 

accommodate the significant interest in 

participation in the oral public 

comment session of ACIP meetings, 

each speaker will be limited to three 

minutes, and each speaker may only 

speak once per meeting. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–19135 Filed 9–5–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Lead Exposure and Prevention 

Advisory Committee 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Lead Exposure and Prevention 

Advisory Committee (LEPAC). This is a 

hybrid meeting which will occur in 

person and online and is open to the 

public. Advance registration by 

September 29, 2023, is needed to 

receive the information to attend the 

meeting. The registration link is 

provided in the addresses section 

below. 

DATES: The meeting will be held on 

October 16, 2023, from 9 a.m. to 4:30 

p.m., EDT and October 17, 2023, from 

9 a.m. to 1 p.m., EDT. 

ADDRESSES: Register in advance at 

https://forms.office.com/pages/

responsepage.aspx?id=eCgFR53Gc0uxes

XQDXVJuPeyypfKOR5G

j2Gz6aPXBGpUREZISTBGV

jczTFlLRU5NUjY0SFN

aQTM0UC4u&web=1&wdLOR=

c61C32E80-28BF-40D7-AC2DE113AEFDAA23 to receive information 

to attend the meeting. 

FOR FURTHER INFORMATION CONTACT: Paul 

Allwood, Ph.D., M.P.H., Designated 

Federal Officer, National Center for 

Environmental Health, Centers for 

Disease Control and Prevention, 4770 

Buford Highway, Atlanta, Georgia 

30341, Telephone: 770–488–6774; 

Email: LEPAC@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Lead Exposure and 

Prevention Advisory Committee was 

established under Section 2203 of 

Public Law 114–322, the Water 

Infrastructure Improvements for the 

Nation Act; 42 U.S.C. 300j–21, Registry 

for Lead Exposure and Prevention 

Advisory Committee. 

Purpose: The LEPAC is charged with 

providing advice and guidance to the 

Secretary, Department of Health and 

Human Services (HHS), and the 

Director, CDC and Administrator, 

ATSDR, on (1) reviewing Federal 

programs and services available to 

individual communities exposed to 

lead; (2) reviewing current research on 

lead exposure to identify additional 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 171 / Wednesday, September 6, 2023 / Notices 60947 

research needs; (3) reviewing and 

identifying best practices, or the need 

for best practices regarding lead 

screening and the prevention of lead 

poisoning; (4) identifying effective 

services, including services relating to 

healthcare, education, and nutrition for 

individuals and communities affected 

by lead exposure and lead poisoning, 

including in consultation with, as 

appropriate, the lead exposure registry 

as established in section 2203(b) of 

Public Law 114–322; and (5) 

undertaking any other review or 

activities that the Secretary determines 

to be appropriate. 

Matters To Be Considered: The agenda 

will include presentations on the 

following topics: aligning HUD 

inspection protocols for assisted 

housing for the last 20 years, the 

environmental factors impacting lead 

reduction, EPA’s proposal on lead dust 

clearance level and hazard standard, 

updates on blood lead testing 

instrument, lead related funding 

opportunities for community-based 

organizations, state policy actions 

related to the blood lead reference 

value, CDC’s efforts to increase blood 

lead testing in children enrolled in 

Medicaid, and an update from the 

Preventing Lead Exposure in Adults 

workgroup. Agenda items are subject to 

change as priorities dictate. 

Public Participation 

Oral Public Comment: The public 

comment period is scheduled on 

October 16, 2023, from 1:30 p.m. until 

2 p.m., and October 17, 2023, from 9:15 

a.m. until 9:45 a.m. EDT. Individuals 

wishing to make a comment during the 

public comment period, please email 

your name, organization, and phone 

number by October 1, 2023, to LEPAC@

cdc.gov. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2023–19134 Filed 9–5–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Community Preventive 

Services Task Force (CPSTF) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: The Centers for Disease 

Control and Prevention, within the 

Department of Health and Human 

Services, announces the next meeting of 

the Community Preventive Services 

Task Force (CPSTF) on October 18–19, 

2023. 

DATES: The meeting will be held on 

Wednesday, October 18, 2023, from 9:00 

a.m. to 5:00 p.m. EDT, and Thursday, 

October 19, 2023, from 9:00 a.m. to 5:00 

p.m. EDT. 

ADDRESSES: The meeting will be 

available to the public via web 

conference. 

FOR FURTHER INFORMATION CONTACT: 

Kenya Turner, Office of Science, Office 

of Scientific Evidence and 

Recommendations, Community Guide 

Program; Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

MS–H21–10, Atlanta, GA 30329. 

Telephone: (404) 718–4592; Email: 

CPSTF@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Meeting Accessibility: The CPSTF 

meeting will be shown via web 

conference. 

All meeting attendees must register by 

October 11, 2023. CDC will email web 

conference login information and the 

agenda to registrants from the CPSTF@

cdc.gov mailbox approximately two 

weeks before the meeting start date. 

To register for the meeting, 

individuals should send an email to 

CPSTF@cdc.gov and include the 

following information: name, title, 

organization name, organization 

address, phone, and email. 

Public Comment: Individuals who 

would like to make public comments 

during the October meeting must state 

their desire to do so in an email to the 

CPSTF@cdc.gov mailbox no later than 

October 11, 2023. The request should 

include name, organizational affiliation, 

and topic to be addressed. Public 

comment must be relevant to one of the 

topics proposed for the meeting. The 

requestor will receive instructions 

related to the public comment process 

for this meeting after the request is 

received. A public comment period 

follows the CPSTF’s discussion of each 

systematic review and will be limited to 

no more than three minutes per person. 

Public comments may be used to inform 

task force discussions and will be 

included in the meeting summary. 

Background on the CPSTF: The 

CPSTF is an independent, nonfederal 

panel whose members are appointed by 

the CDC Director. CPSTF members 

represent a broad range of research, 

practice, and policy expertise in 

prevention, wellness, health promotion, 

and public health. The CPSTF was 

convened in 1996 by HHS to identify 

community preventive programs, 

services, and policies that increase 

health and longevity, save lives and 

dollars, and improve Americans’ quality 

of life. CDC is mandated to provide 

ongoing administrative, research, and 

technical support for the operations of 

the CPSTF. During its meetings, the 

CPSTF considers the findings of 

systematic reviews of existing research 

and practice-based evidence, and issues 

recommendations. CPSTF 

recommendations are not mandates for 

compliance or spending. Instead, they 

provide information about evidencebased options that decision makers and 

affected community members can 

consider when they are determining 

what best meets the specific needs, 

preferences, available resources, and 

constraints of their jurisdictions and 

constituents. The CPSTF’s 

recommendations, along with the 

systematic reviews of the evidence on 

which they are based, are compiled on 

the Community Guide website 

(www.thecommunityguide.org). 

Matters proposed for discussion: The 

agenda will consist of deliberation on 

systematic reviews of literature. Topics 

proposed for the October 2023 meeting 

include cancer, preparedness and 

response, social determinants of health, 

and substance use. Changes regarding 

the start and end times for each day, and 

any updates to agenda topics, will be 

available on the Community Guide 

website (www.thecommunityguide.org) 

closer to the date of the meeting. The 

meeting agenda is subject to change 

without notice. 

Tiffany Brown, 

Executive Secretary, Centers for Disease 

Control and Prevention. 

[FR Doc. 2023–19150 Filed 9–5–23; 8:45 am] 

BILLING CODE 4163–18–P 


lotter on DSK11XQN23PROD with NOTICES1